respiratori
infect
bacteria
virus
often
trigger
symptom
asthma
adult
children
observ
subsequ
mechanist
studi
demonstr
import
interact
among
allergen
microb
atop
host
mechan
respons
microbeinduc
asthma
exacerb
incomplet
understood
focal
point
current
research
inflammatori
respons
host
follow
encount
pathogen
microb
includ
variat
chemokin
cytokin
product
result
chang
bronchial
hyperrespons
lung
function
direct
bronchial
infect
exposur
nerv
result
neurogen
inflamm
deviat
host
immun
respons
among
mechan
underli
function
disord
late
suboptim
innat
immun
respons
express
defect
interferon
product
gain
attent
might
amen
intervent
review
describ
suggest
mechan
involv
complex
interact
asthmagen
microb
immun
system
atopi
base
invitro
invivo
experiment
model
epidemiolog
evid
addit
provid
synopsi
potenti
therapeut
strategi
either
directli
microorgan
respect
associ
inflamm
preval
allergi
asthma
increas
especi
children
last
sever
decad
modern
lifestyl
variou
environment
factor
significantli
influenc
onset
complex
chronic
disord
consider
research
effort
focus
potenti
effect
exposur
pollut
aeroallergen
infecti
agent
could
advers
affect
lung
develop
function
also
precipit
asthma
exacerb
wide
recogn
respiratori
viral
infect
among
import
trigger
asthma
exacerb
children
adult
associ
upper
respiratori
viral
infect
asthma
exacerb
children
demonstr
almost
three
decad
ago
use
viru
cultur
serolog
techniqu
find
subsequ
confirm
expand
use
sensit
techniqu
viru
detect
revers
transcript
polymeras
chain
reaction
rtepcr
assay
welldesign
longitudin
studi
implement
techniqu
report
episod
wheez
drop
lung
function
could
attribut
respiratori
viral
infect
rhinoviru
rv
preval
viru
similar
studi
adult
implic
respiratori
pathogen
almost
half
exacerb
rhinoviru
prevail
viru
abbrevi
rtepcr
revers
transcriptionepolymeras
chain
reaction
rv
rhinoviru
piv
parainfluenza
viru
rsv
respiratori
syncyti
viru
mpv
human
metapneumoviru
intracellular
adhes
ifnb
interferonbeta
ngf
nerv
growth
factor
sp
substanc
p
neurokinin
receptor
mbl
mannosebind
lectin
laba
longact
b
agonist
addit
evid
associ
atyp
bacteri
respiratori
pathogen
pathogenesi
asthma
mycoplasma
pneumonia
chlamydophila
pneumonia
commonli
implic
howev
mani
studi
investig
link
uncontrol
provid
controversi
evid
mainli
reflect
difficulti
accur
diagnos
infect
pathogen
take
account
strong
associ
conceiv
antimicrobi
agent
andor
strategi
may
potenti
reduc
burden
asthmaassoci
morbid
major
virus
implic
pathogenesi
asthma
exacerb
singlestrand
rna
virus
includ
rv
influenza
parainfluenza
piv
virus
respiratori
syncyti
viru
rsv
coronavirus
newli
describ
human
metapneumoviru
mpv
bocaviru
among
doublestrand
dna
virus
adenovirus
also
involv
human
respiratori
tract
agent
abl
produc
spectrum
clinic
acut
infect
phenotyp
rang
common
cold
croup
acut
bronchiol
pneumonia
although
viru
increas
propens
particular
clinic
diseas
eg
parainfluenza
croup
rsv
sever
bronchiol
influenza
pneumonia
evid
adenoviru
also
caus
latent
infect
human
lung
spectrum
viraltrigg
asthma
exacerb
report
viral
preval
may
vari
accord
variou
factor
age
subject
import
sinc
overal
frequenc
viral
respiratori
ill
highest
children
year
age
gradual
declin
teenag
rise
young
parent
expos
children
redeclin
older
adult
elderli
suscept
addit
respiratori
viral
infect
strong
season
pattern
although
sporad
case
nosocomi
outbreak
occur
presenc
absenc
lipidcontain
envelop
affect
viral
surviv
environ
temper
area
envelop
virus
eg
influenza
viru
rsv
coronaviru
characterist
preval
middlewint
period
wherea
nonenvelop
one
rv
found
often
spring
fall
rv
characterist
produc
epidem
soon
children
return
school
septemb
epidem
asthma
exacerb
coincid
increas
rate
respiratori
track
infect
evid
differ
infecti
agent
may
induc
asthma
exacerb
vari
sever
howev
stronger
evid
need
respect
final
type
diagnost
test
use
identifi
infect
may
consider
affect
epidemiolog
result
although
rsv
remain
agent
associ
major
case
bronchiol
requir
hospit
recent
evid
suggest
commun
rv
preval
viru
age
furthermor
except
studi
assess
virusinduc
exacerb
asthma
shown
rv
preval
agent
attribut
virusconfirm
case
around
half
exacerb
studi
also
evid
rv
may
asthmagen
virus
papadopoulo
et
al
unpublish
rv
belong
picornavirida
famili
probabl
repres
abund
pathogen
microorgan
univers
virus
small
rna
genom
nonenvelop
capabl
surviv
surfac
sever
hour
ambient
condit
serotyp
rv
identifi
number
divid
major
minor
group
depend
receptor
specif
major
rv
attach
intracellular
adhes
minor
group
rv
bind
lowdens
lipoprotein
receptor
vitro
vivo
rv
infect
bronchial
epithelium
upregul
rang
proinflammatori
cytokin
chemokin
adhes
molecul
mucin
growth
factor
thought
contribut
lower
airway
inflamm
consequ
effect
lung
function
larg
number
mediat
upregul
partli
sole
transcript
factor
nfkb
sever
mechan
suggest
part
complic
pathway
lead
viral
infect
acut
asthma
exacerb
includ
direct
infect
lower
respiratori
tract
induct
local
inflamm
increas
bronchial
reactiv
induct
bronchial
obstruct
local
inflamm
produc
bronchial
epitheli
cell
infect
neurogen
inflamm
induc
directli
indirectli
epithelium
immun
respons
host
probabl
import
increas
evid
epithelium
lower
airway
simpli
act
physic
barrier
import
regulatori
role
immun
respons
inasmuch
may
act
antigen
present
structur
also
contribut
inflammatori
respons
follow
viral
infect
product
cytokin
chemokin
eg
tnfa
rant
gmscf
eotaxin
eotaxin
attract
inflammatori
cell
involv
asthma
exacerb
epitheli
cell
structur
function
alter
infiltr
inflammatori
cell
oedema
airway
wall
recent
suggest
epitheli
cell
asthmat
subject
may
abnorm
innat
respons
infect
rv
result
increas
viru
replic
cell
lysi
compar
cell
healthi
normal
control
cell
asthmat
individu
produc
enough
interferonbeta
ifnb
respons
infect
lead
reduc
apoptosi
rate
consequ
increas
viral
replic
within
cell
final
increas
cytotox
increas
viral
load
anoth
propos
mechan
acut
infect
might
enhanc
airway
narrow
hyperrespons
stimul
airway
neural
network
may
lead
neurogen
inflamm
virusmedi
damag
epitheli
layer
expos
dens
subepitheli
nerv
end
increas
stimul
sensori
nerv
inhal
particl
proinflammatori
mediat
sensori
nerv
directli
releas
neuropeptid
may
trigger
reflex
bronchoconstrict
among
mediat
neurogen
inflamm
nerv
growth
factor
ngf
may
import
role
pathogenesi
hyperrespons
induc
respiratori
virus
document
ngf
induc
select
upregul
highaffin
neurokinin
receptor
tachykinin
substanc
p
sp
sp
neuropeptid
releas
sensori
nerv
bronchoconstrict
effect
immunomodulatori
properti
regul
function
white
blood
cell
affect
migrat
respons
variou
mitogen
allergen
one
recent
studi
focus
neural
develop
lung
earli
life
propos
process
control
ngf
correspond
receptor
trka
factor
control
branch
nerv
develop
lung
downregul
age
ngf
strongli
upregul
rsv
infect
especi
infant
overexpress
may
result
prolong
viral
clearanc
infect
epitheli
cell
final
anoth
interest
pathway
attribut
protract
inflamm
associ
imbal
h
h
immun
respons
lower
airway
atop
asthmat
individu
h
environ
predomin
although
ifng
cytokin
produc
normal
atop
asthmat
subject
ratio
consider
reduc
asthmat
compar
normal
subject
furthermor
atop
individu
may
impair
antivir
respons
concern
ifna
ifnb
orand
ifng
reduc
secret
someth
may
result
prolong
bronchial
inflamm
increas
asthma
sever
also
demonstr
impair
extend
cell
recruit
sinc
asthmat
patient
seem
increas
number
eosinophil
compar
normal
individu
also
indic
differ
immun
respons
viral
infect
natur
histori
asthma
exacerb
interact
viral
infect
environment
stimuli
often
note
sever
occas
synergist
effect
shown
import
impli
therapeut
result
may
occur
treatment
one
factor
associ
upper
respiratori
tract
infect
air
pollut
especi
tobacco
smoke
exposur
observ
children
sever
potenti
mechan
pollut
exacerb
asthma
interact
respiratori
viral
infect
direct
effect
pollut
airway
includ
epitheli
damag
acquir
ciliari
dyskinesia
releas
proinflammatori
mediat
increas
ige
concentr
may
follow
indirectli
also
impair
local
antivir
immun
airway
recent
studi
suggest
virus
allergen
may
synergist
effect
individu
asthma
shown
clinic
outcom
symptom
sever
experiment
model
evid
viral
infect
enhanc
allergen
induc
inflammatori
respons
eosinophil
recruit
histamin
releas
late
phase
airway
respons
although
increas
evid
control
studi
support
associ
atyp
bacteri
infect
chronic
stabl
asthma
acut
exacerb
asthma
still
unclear
whether
associ
causal
patient
asthma
suscept
colon
andor
infect
atyp
bacteria
nevertheless
case
report
also
control
trial
sever
decad
suggest
postinfecti
wheez
may
respond
antibiot
therapi
particular
macrolid
problem
diagnost
techniqu
acut
chronic
infect
mycoplasma
pneumonia
chlamydophila
pneumonia
made
difficult
conduct
interpret
epidemiolog
studi
potenti
relat
microorgan
asthma
add
complex
macrolid
ketolid
shown
antiinflammatori
properti
make
difficult
assess
true
role
infect
asthmat
patient
exacerb
associ
increas
antibodi
titr
chlamydophila
pneumonia
mycoplasma
pneumonia
recent
propos
c
pneumonia
might
modul
epitheli
cell
apoptosi
upregul
proapoptosi
antiapoptosi
gene
suggest
c
pneumoniaeinduc
inhibit
apoptosi
increas
longev
host
cell
enhanc
surviv
c
pneumonia
patient
chronic
asthma
consequ
bronchial
infect
atyp
bacteria
like
associ
increas
airway
inflamm
thu
possibl
increas
asthma
sever
airway
remodel
although
organ
common
caus
infect
infect
patient
develop
exacerb
asthma
suggest
certain
individu
may
genet
predispos
chronic
effect
atyp
bacteria
genet
suscept
infect
render
like
persist
infect
studi
investig
possibl
suscept
one
isotypespecif
serolog
test
perform
c
pneumonia
result
compar
variat
mannosebind
lectin
mbl
complement
compon
import
clearanc
respiratori
pathogen
presenc
variant
allel
mbl
associ
increas
suscept
type
respiratori
infect
significantli
increas
risk
asthma
develop
among
children
infect
c
pneumonia
hand
recent
studi
detail
show
improv
outcom
ketolid
use
patient
asthma
exacerb
although
much
progress
understand
mechan
microbeinduc
asthma
exacerb
need
develop
new
therapeut
agent
well
prevent
strategi
antimicrobi
immun
modul
could
therapeut
benefit
respect
rhinoviru
key
viru
account
major
exacerb
children
adult
thu
effect
treatment
prevent
infect
would
major
asset
asthma
therapi
unfortun
current
avail
antivir
therapi
clinic
valu
vaccin
seem
far
away
larg
number
rv
serotyp
although
genet
divers
hamper
vaccin
develop
modern
vaccin
strategi
recombin
protein
revers
genet
replic
defect
particl
techniqu
may
make
feasibl
induc
crossreact
neutral
antibodi
major
serotyp
produc
effect
vaccin
contrast
rv
rsv
gain
attent
associ
sever
bronchiol
infanc
ribavirin
although
initi
promis
find
place
major
case
although
still
includ
among
possibl
choic
sever
bronchiol
passiv
immunoprophylaxi
monthli
administr
antif
monoclon
antibodi
palivizumab
reduc
risk
lower
respiratori
tract
rsv
diseas
hospit
highrisk
infant
children
howev
use
wide
outpati
basi
vaccin
rsv
avail
yet
studi
intranas
liveattenu
vaccin
children
inject
subunit
vaccin
elderli
person
ongo
influenza
virus
b
caus
annual
outbreak
ill
worldwid
varieti
antivir
agent
avail
treatment
influenza
previou
gener
agent
amantadin
rimantadin
demonstr
clinic
efficaci
howev
potenti
side
effect
importantli
resist
consider
reduc
use
recent
neuraminidas
inhibitor
zanamivir
oseltamivir
activ
b
virus
includ
avian
influenza
strain
promis
import
tool
pandem
possibl
antiinfluenza
agent
explor
influenza
vaccin
avail
two
form
intramuscular
prepar
contain
formalininactiv
viru
purifi
surfac
antigen
intranas
spray
contain
live
attenu
virus
efficaci
vaccin
approxim
young
adult
especi
vaccin
antigen
circul
strain
close
match
immun
healthi
work
adult
associ
fewer
upper
respiratori
ill
fewer
visit
physician
offic
howev
use
influenza
vaccin
reduc
virusinduc
exacerb
remain
controversi
concern
asthmagen
virus
coronavirus
adenovirus
human
metapneumoviru
bocaviru
clinic
avail
therapeut
prophylact
agent
still
await
mention
causal
link
defici
interferonimpair
apoptosi
increas
viru
replic
demonstr
suggest
type
interferon
might
use
treatment
prevent
virusinduc
asthma
exacerb
type
ifn
includ
numer
ifna
ifnb
newli
identifi
ifnl
past
shown
effect
given
prior
experiment
rv
infect
prophylact
therapi
context
natur
rv
infect
howev
cost
sideeffect
prevent
exploit
common
cold
andor
asthma
exacerb
field
ifnb
effect
prevent
experiment
natur
rv
cold
effect
asthma
exacerb
investig
promis
data
recent
publish
ifnl
note
addit
antivir
approach
combin
ifna
intranas
ipratropium
oral
naproxen
chlorpheniramin
ibuprofen
test
promis
result
also
commerci
although
quit
activ
vitro
glucocorticosteroid
gc
far
disappoint
abil
control
symptom
model
experiment
rv
challeng
asthmat
highdos
steroid
remain
partial
effect
control
virusinduc
exacerb
asthma
synergist
effect
gc
longact
b
agonist
laba
shown
vitro
studi
clinic
laba
act
via
g
protein
coupl
receptor
activ
adenyl
cyclas
second
messeng
camp
induc
intracellular
signal
event
affect
broad
rang
physiolog
process
provid
way
extra
potenti
enhanc
antiinflammatori
properti
gc
act
togeth
combin
therapi
studi
confirm
clinic
benefit
exacerb
although
viral
origin
event
confirm
evid
suggest
leukotrien
play
key
role
viralinduc
respiratori
ill
leukotrien
receptor
antagonist
montelukast
proven
efficaci
control
asthma
exacerb
adult
also
preschool
school
children
persist
intermitt
asthma
addit
montelukast
significantli
reduc
symptom
exacerb
respiratori
syncyti
viru
postbronchiol
infant
without
asthma
agent
includ
antihistamin
antioxid
block
proinflammatori
mechan
induc
viru
infect
airway
epitheli
cell
although
vitro
evid
parallel
convinc
clinic
data
although
viral
infect
major
interest
potenti
role
antibacteri
therapi
also
discuss
number
differ
antibacteri
agent
name
tetracyclin
macrolid
quinolon
azalid
ketolid
telithromycin
vitro
vivo
activ
common
atyp
bacteria
c
pneumonia
pneumonia
clarithromycin
roxithromycin
azithromycin
recent
telithromycin
shown
clinic
benefit
patient
chronic
stabl
asthma
acut
exacerb
recent
publish
doubleblind
random
placebocontrol
studi
telithromycin
daili
dose
mg
day
provid
improv
symptom
lung
function
among
adult
patient
acut
exacerb
asthma
studi
design
incorpor
analysi
mechan
telithromycin
associ
improv
data
impli
benefit
sole
attribut
antimicrobi
effect
note
resist
need
also
consid
initi
long
term
therapi
order
control
prevent
probabl
bacteriainduc
asthma
attack
although
promis
mani
question
answer
antibacteri
therapi
propos
treatment
prevent
asthma
exacerb
certainli
combin
antimicrobi
antiinflammatori
approach
seem
reason
evid
suggest
window
opportun
exist
appear
viral
infect
initi
exacerb
hand
control
studi
macrolid
especi
children
urgent
need
manag
exacerb
import
unmet
need
age
group
